|
KPNA6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32730049173801E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47289982830057E-10 |
| Normal-vs-Stage2 |
4.682200E-03 |
| Normal-vs-Stage3 |
4.379500E-03 |
| Normal-vs-Stage4 |
3.661700E-02 |
| Stage1-vs-Stage2 |
7.432800E-01 |
| Stage1-vs-Stage3 |
6.021600E-01 |
| Stage1-vs-Stage4 |
7.441400E-01 |
| Stage2-vs-Stage3 |
9.141800E-01 |
| Stage2-vs-Stage4 |
6.385400E-01 |
| Stage3-vs-Stage4 |
5.883600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6275005221853E-10 |
| Normal-vs-AfricanAmerican |
5.05739999989707E-07 |
| Normal-vs-Asian |
4.110100E-02 |
| Caucasian-vs-AfricanAmerican |
8.486800E-01 |
| Caucasian-vs-Asian |
5.357000E-01 |
| AfricanAmerican-vs-Asian |
5.514400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15019105351166E-12 |
| Normal-vs-Female |
1.652060E-02 |
| Male-vs-Female |
5.637800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.754410E-04 |
| Normal-vs-Extreme_Weight |
6.93367585569149E-12 |
| Normal-vs-Obese |
1.649630E-04 |
| Normal-vs-Extreme_Obese |
9.703200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.807400E-01 |
| Normal_Weight-vs-Obese |
4.605600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.640400E-01 |
| Extreme_Weight-vs-Obese |
6.692400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.628200E-01 |
| Obese-vs-Extreme_Obese |
6.743800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.255600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.94039999956708E-07 |
| Normal-vs-Age(61-80Yrs) |
1.88909998755094E-10 |
| Normal-vs-Age(81-100Yrs) |
2.99010000093247E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.813400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.615050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.966300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.604000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.293830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.38529998583437E-09 |
| Normal-VS-Type2 PRCC |
6.81040002170619E-09 |
| Normal-VS-KIRP CIMP |
8.329800E-01 |
| Normal-VS-Unclassified PRCC |
3.221200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.068000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.386810E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.940200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.970200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.046970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.348200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02159947168445E-10 |
| Normal-vs-N1 |
9.430300E-02 |
| Normal-vs-N2 |
7.687000E-01 |
| N0-vs-N1 |
1.868800E-01 |
| N0-vs-N2 |
5.079200E-01 |
| N1-vs-N2 |
7.635800E-01 |
|
|
